MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$9,686K
Research and development
incentive receivable
$743K
Prepaid expenses and
other current assets
$69K
Total current assets
$10,498K
Deposits
$783K
Deferred costs
$80K
Right of use assets,
net
$38K
Total assets
$11,399K
Total liabilities and
stockholders' equity
$11,399K
Total liabilities
$8,704K
Total stockholders'
equity
$2,695K
Accumulated deficit
-$502,752K
Accumulated other
comprehensive loss
-$104K
Total current
liabilities
$8,704K
Additional paid-in capital
$505,510K
Common stock, 0.001 par
value 240,000,000...
$41K
Accounts payable
$4,279K
Accrued expenses
$3,860K
Income tax payable
$527K
Lease liability
$38K
Back
Back
Balance Sheet
source: myfinsight.com
LEAP THERAPEUTICS, INC. (LPTX)
LEAP THERAPEUTICS, INC. (LPTX)